Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ann R Coll Surg Engl ; 103(4): 263-271, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33557701

RESUMO

INTRODUCTION: Basal cell carcinoma is the most common cancer. Excisional surgery is associated with a high clearance rate, at the expense of significant functional and aesthetic morbidity, especially within the T-zone or for extensive lesions. We report five-year follow-up outcomes for carbon dioxide laser extirpation of cutaneous basal cell carcinoma, assisted by immediate methyl aminolevulinate photodynamic therapy and cost-benefit considerations. MATERIALS AND METHODS: Retrospective cohort database analysis of adult patients with biopsy-proven primary cutaneous basal cell carcinoma, completing five years of follow-up. Direct per-lesion cost was compared with conventional wide local excision. Patients with morphoeic basal cell carcinoma were excluded. RESULTS: Treated lesions were up to 1% total body surface area and up to 3.8mm (1.38 ± 0.695cm, mean ± standard deviation) in biopsy-proven depth. At the five-year follow-up mark, 93.6% of treated areas remained free of recurrence. Nodular basal cell carcinoma was the most common subtype (41.5%). A mean tumour depth greater than 2 ± 0.872mm was significantly associated with recurrence (Mann-Whitney, p = 0.0487). For a service delivered through the NHS at 2015 prices, we report a 43% saving, equating to a saving of £235 per basal cell carcinoma or a national annualised saving of £70 million by 2025 for the NHS. CONCLUSION: Our results suggest that CO2-assisted photodynamic therapy is non-inferior to excision but may offer better functional and cosmetic preservation at a fraction of the direct like for like cost of operative surgery. Investigation of this method by randomised controlled methodology is warranted.


Assuntos
Ácido Aminolevulínico/análogos & derivados , Carcinoma Basocelular/terapia , Procedimentos Cirúrgicos Dermatológicos/métodos , Lasers de Gás/uso terapêutico , Fotoquimioterapia/métodos , Fármacos Fotossensibilizantes/uso terapêutico , Neoplasias Cutâneas/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Ácido Aminolevulínico/economia , Ácido Aminolevulínico/uso terapêutico , Carcinoma Basocelular/economia , Terapia Combinada , Análise Custo-Benefício , Procedimentos Cirúrgicos Dermatológicos/economia , Feminino , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Fotoquimioterapia/economia , Fármacos Fotossensibilizantes/economia , Estudos Retrospectivos , Neoplasias Cutâneas/economia , Resultado do Tratamento , Reino Unido
2.
Cases J ; 2: 129, 2009 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-19200372

RESUMO

INTRODUCTION: This study documents the first reported case of a rapidly growing (volar) thenar eminence ganglion arising form the first carpometacarpal joint, masquerading as a sarcoma. The discussion informs the hand surgeon on the evidence regarding the unusual presenting features. CASE PRESENTATION: An 85 year old left hand dominant female presented with a six week history of rapidly growing lump on the thenar eminence. Clinical examination revealed a non-tender large lobulated mobile swelling measuring 5 x 4 cm and involving the whole thenar eminence. CONCLUSION: Ganglia may present from the thenar eminence and are a source of diagnostic confusion.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA